These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12418583)

  • 1. Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis.
    Aubier M; Aldons PM; Leak A; McKeith DD; Leroy B; Rangaraju M; Bienfait-Beuzon C
    Respir Med; 2002 Nov; 96(11):862-71. PubMed ID: 12418583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis.
    Luterman M; Tellier G; Lasko B; Leroy B
    Ear Nose Throat J; 2003 Aug; 82(8):576-80, 82-4, 586 passim. PubMed ID: 14503094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telithromycin for the treatment of acute exacerbations of chronic bronchitis.
    Fogarty C; Zervos M; Tellier G; Aubier M; Rangaraju M; Nusrat R
    Int J Clin Pract; 2005 Mar; 59(3):296-305. PubMed ID: 15857326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
    Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E
    Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telithromycin.
    Wellington K; Noble S
    Drugs; 2004; 64(15):1683-94; discussion 1695-6. PubMed ID: 15257629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Fisher CL; Busman T; Olson CA
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
    Quinn J; Ruoff GE; Ziter PS
    Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
    Tellier G; Brunton SA; Nusrat R
    South Med J; 2005 Sep; 98(9):863-8. PubMed ID: 16217977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis.
    Roos K; Tellier G; Baz M; Leroy B; Rangaraju M
    J Infect; 2005 Apr; 50(3):210-20. PubMed ID: 15780415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
    Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
    Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis.
    Norrby SR; Rabie WJ; Bacart P; Mueller O; Leroy B; Rangaraju M; Butticaz-Iroudayassamy E
    Scand J Infect Dis; 2001; 33(12):883-90. PubMed ID: 11868759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin-clavulanate in the treatment of acute bacterial sinusitis.
    Desrosiers M; Ferguson B; Klossek JM; Drugeon H; Mösges R
    Curr Med Res Opin; 2008 Jun; 24(6):1691-702. PubMed ID: 18559163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L; Hassman J; Tellier G
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance in practice: bacteriological efficacy in patients with drug-resistant S. pneumoniae.
    Garau J
    Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():28-35. PubMed ID: 14759231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.